review Open AccessTop 1% cited

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

Nature reviews. Cancer · 2006 · Vol. 6(1) · pp. 38–51

Saverio Minucci✉(European Institute of Oncology)Pier Giuseppe Pelicci(European Institute of Oncology)

Histone Deacetylase Inhibitors Research Protein Degradation and Inhibitors Epigenetics and DNA MethylationHistone deacetylaseEpigeneticsHistoneContext (archaeology)VorinostatHistone deacetylase inhibitorCarcinogenesisCancer researchComputational biologyCancer

MeSH terms

Histone DeacetylasesHumansNeoplasmsEpigenesis, GeneticHistone AcetyltransferasesHistone Deacetylase Inhibitors

Citations

2,190

FWCI

73.30

field-weighted impact

References

145

Percentile

100%

vs. same field & year

Citations per year

Cited by

Histone Deacetylase Inhibitors as Anticancer Drugs

International Journal of Molecular Sciences · 2017 · 1,159 citations

Anticancer activities of histone deacetylase inhibitors

Nature Reviews Drug Discovery · 2006 · 2,905 citations

HDAC family: What are the cancer relevant targets?

Cancer Letters · 2008 · 1,047 citations

Cellular senescence: when bad things happen to good cells

Nature Reviews Molecular Cell Biology · 2007 · 4,259 citations

The Epigenomics of Cancer

Cell · 2007 · 4,415 citations

Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy

Cancer Letters · 2008 · 425 citations

Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders

Nature Reviews Drug Discovery · 2014 · 1,501 citations

Histone deacetylase inhibitors: molecular mechanisms of action

Oncogene · 2007 · 1,533 citations

References

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

Nature Reviews Drug Discovery · 2002 · 1,513 citations

The language of covalent histone modifications

Nature · 2000 · 8,530 citations

Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion

The EMBO Journal · 2003 · 1,236 citations

The history of cancer epigenetics

Nature reviews. Cancer · 2004 · 2,348 citations

Acetylation: a regulatory modification to rival phosphorylation?

The EMBO Journal · 2000 · 1,150 citations

Stem cells, cancer, and cancer stem cells

Nature · 2001 · 9,682 citations

Class II histone deacetylases: versatile regulators

Trends in Genetics · 2003 · 655 citations

Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.